BridgeBio Oncology Q1 EPS $(526.11) Down From (54.230) YoY,

Benzinga Newsdesk www.benzinga.com Negative 96.4%

Neg 96.4% Neu 0% Pos 0%

BridgeBio Oncology (NASDAQ:BBOT) reported quarterly losses of $(526.11).This is a 870.15 percent decrease over losses of $(54.23) per share from the same period last year.